| Primary |
| Product Used For Unknown Indication |
56.7% |
| Urinary Tract Infection |
9.6% |
| Pneumonia |
3.2% |
| Streptococcal Sepsis |
3.2% |
| Grand Mal Convulsion |
2.5% |
| Lower Respiratory Tract Infection |
2.5% |
| Nosocomial Infection |
2.5% |
| Sepsis |
2.5% |
| Cholecystitis |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Hypertension |
1.9% |
| Postoperative Analgesia |
1.9% |
| Antibiotic Prophylaxis |
1.3% |
| Hospital Acquired Infection |
1.3% |
| Liver Abscess |
1.3% |
| Neonatal Respiratory Distress Syndrome |
1.3% |
| Uti |
1.3% |
| Vascular Dementia |
1.3% |
| Wound Infection |
1.3% |
| Acute Sinusitis |
0.6% |
|
| Vomiting |
21.1% |
| Myocardial Ischaemia |
7.9% |
| Renal Failure Acute |
7.9% |
| Toxic Encephalopathy |
7.9% |
| Anaphylactic Reaction |
5.3% |
| Incorrect Dose Administered |
5.3% |
| Rash Pruritic |
5.3% |
| Small Intestinal Obstruction |
5.3% |
| Vaginal Ulceration |
5.3% |
| Blood Creatine Phosphokinase Increased |
2.6% |
| Clostridium Difficile Infection |
2.6% |
| Clostridium Test Positive |
2.6% |
| Haematuria |
2.6% |
| Jaundice |
2.6% |
| Malaise |
2.6% |
| Pain |
2.6% |
| Prothrombin Time Ratio Decreased |
2.6% |
| Pruritus Generalised |
2.6% |
| Rash |
2.6% |
| Rash Generalised |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
34.7% |
| Urinary Tract Infection |
12.3% |
| Streptococcal Sepsis |
9.3% |
| Prostatitis |
7.5% |
| Ulcer |
6.3% |
| Grand Mal Convulsion |
5.2% |
| Foetal Exposure During Pregnancy |
4.5% |
| Drug Use For Unknown Indication |
3.7% |
| Pneumonia |
3.7% |
| Vascular Dementia |
1.9% |
| Pancreatitis |
1.5% |
| Pancreatitis Necrotising |
1.5% |
| Sepsis |
1.5% |
| Tonic-clonic Seizures |
1.5% |
| Bronchitis |
1.1% |
| Arthritis Infective |
0.7% |
| Cardiac Failure |
0.7% |
| Hospital Acquired Infection |
0.7% |
| Hypertension |
0.7% |
| Iron Deficiency Anaemia |
0.7% |
|
| Vomiting |
26.9% |
| Clostridium Test Positive |
11.9% |
| Premature Baby |
9.0% |
| Weight Decreased |
9.0% |
| Urinary Tract Infection |
7.5% |
| Blood Creatine Phosphokinase Increased |
6.0% |
| Mouth Ulceration |
4.5% |
| Wheezing |
4.5% |
| Hepatitis |
3.0% |
| Renal Failure Acute |
3.0% |
| Clostridium Difficile Infection |
1.5% |
| Diarrhoea |
1.5% |
| Diverticulitis |
1.5% |
| Jaundice Cholestatic |
1.5% |
| Motor Dysfunction |
1.5% |
| Respiratory Failure |
1.5% |
| Skin Fissures |
1.5% |
| Syncope |
1.5% |
| Urticaria |
1.5% |
| Withdrawal Syndrome |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
68.8% |
| Infection |
4.3% |
| B-cell Lymphoma |
3.1% |
| Nausea |
2.7% |
| Pneumonia |
2.5% |
| Non-small Cell Lung Cancer Stage Iiia |
2.1% |
| Anxiety |
1.7% |
| Pulmonary Embolism |
1.7% |
| Osteoarthritis |
1.6% |
| Blood Potassium Decreased |
1.2% |
| Constipation |
1.2% |
| Lower Respiratory Tract Infection |
1.2% |
| Neutropenia |
1.2% |
| Oedema |
1.2% |
| Pain |
1.2% |
| Arthralgia |
1.0% |
| Nodular (Follicular) Lymphoma |
1.0% |
| Urinary Tract Infection |
1.0% |
| Acute Coronary Syndrome |
0.8% |
| Anaemia |
0.8% |
|
| Thrombocytopenia |
12.5% |
| Hypomagnesaemia |
9.4% |
| Hypotension |
7.8% |
| Lip Swelling |
7.8% |
| Meningitis |
7.8% |
| Scab |
7.8% |
| Toxic Epidermal Necrolysis |
7.8% |
| Pneumonia |
4.7% |
| Respiratory Failure |
4.7% |
| Death |
3.1% |
| Medication Error |
3.1% |
| Pancreatitis |
3.1% |
| Peripheral Arterial Occlusive Disease |
3.1% |
| Premature Labour |
3.1% |
| Supraventricular Tachycardia |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Vasculitis |
3.1% |
| Acute Myocardial Infarction |
1.6% |
| Arthralgia |
1.6% |
| Bradyarrhythmia |
1.6% |
|
